Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar ...
Swiss drugmaker Sandoz launched its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira biosimilar to hit the U.S. market, priced at a 5% and 55% ...
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
Due to slow uptake of its Humira biosimilar Cyltezo in the U.S., Boehringer Ingelheim is laying off an undisclosed number of ...
ANNOUNCER: 'Think Tank' has been made possible by Amgen, arecipient of the Presidential National Medal of Technology. Amgen,bringing better, healthier lives to people worldwide throughbiotechnology.
Even with discounts that reach as high as 86%, Humira biosimilars are finding it difficult to take market share away from the ...
Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor US sales of its biosimilar version of AbbVie’s blockbuster arthritis treatment Humira. The German drugmaker ...
, opens new tab said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on early-stage study of its experimental schizophrenia drug, sending its shares down more than 23% ...
ANNOUNCER: ’Think Tank’ has been made possible by Amgen, a recipient of the Presidential National Medal of Technology. Amgen, bringing better, healthier lives to people worldwide through ...